Case B takes up the story in August 2001, when executives at Pfizer were grappling with how to defend Lipitor's market leadership, then worth $5 billion. How should they prepare for the arrival of ...

AstraZeneca is to sell European rights to its cholesterol drug Crestor (rosuvastatin) to Germany’s Grunenthal. Crestor is a statin and at its peak generated annual revenues of more than $7 ...